CGAS and melanoma: A vaccine-based therapy involving the injection of irradiated B16 OVA cells containing a 90-bp 5′-modified AT-rich dsDNA—thus a cGAS ligand—into mice with metastatic B16 melanoma resulted in prolonged survival as compared with the control [28].